Hot Flasher

Hot Flasher
  • 0,0 (0)
  • Sessualità
  • Ogni giorno

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

  1. 1 g fa

    Not Knowing If It Counts: The Perimenopause Uncertainty Study

    A new NAMS study officially names perimenopause uncertainty as a clinically distinct and widespread experience — and explains why so many women feel dismissed or confused before they ever get a diagnosis. This episode also covers a promising randomized trial on compassionate mind training for menopause-related mood and anxiety, and takes a hard look at what "shows promise" actually means when a supplement brand uses it in a headline. Key Takeaways: • Perimenopause uncertainty — not knowing whether your symptoms are perimenopause or something else — is now recognized in peer-reviewed research as a clinically meaningful phenomenon, distinct from illness-related uncertainty. • The uncertainty isn't just uncomfortable; it delays validation, delays care, and has real mental health consequences for women in the transition. • Compassionate Mind Training (CMT), a structured group intervention rooted in self-compassion and emotion regulation, showed feasibility and early signal for reducing anxiety and low mood in a randomized controlled trial — though a fully powered effectiveness trial still needs to happen. • Elysium's NR-based supplement generated a headline claiming it "shows promise" for menopause symptoms — but the source is NutraIngredients, a trade publication, not a peer-reviewed journal, and no independent trial data was available at time of publishing. • For mood and anxiety specifically, non-hormonal, evidence-adjacent options like CMT are worth watching — particularly for women who can't or don't want to use HRT. Sources & References: • Perimenopause uncertainty prevalence and drivers: a mixed-methods study (https://pubmed.ncbi.nlm.nih.gov/42445976/) - Menopause (NAMS Journal) • Compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal) • Elysium's supplement shows promise for menopause symptoms (https://news.google.com/rss/articles/CBMiqwFBVV95cUxOM1FUajFEUktpXzkwSXZReDVkcHVGQ2YwZ1gyVnZjX2ZHMzdkWnVPVjlSQ1p1UXYyMDN4ZnV4S2dHcXhxVUpsOVVnLTZfUDQwZWhiSEFlNUFCdG5XdGp2dzJZRHhQUlZwLXcwdWpVSGhiRG9hS29SLWZvV016emt2VjNkalIwN2xxWVhSSi0yRE51WnFGM0tpUFhoRXJWN05fMVJ5RzlfRnZsVVE) - NutraIngredients.com Listen with full show notes: https://hotflasher.com/episodes/2026-07-24-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  2. 2 gg fa

    Three Doctors Later: The Diagnosis Gap That Affects Every Woman

    This episode covers the systemic gaps in menopause diagnosis and treatment, anchored by Melinda French Gates's account of needing three doctors to identify her perimenopause, new Medscape data showing Medicaid patients are half as likely to receive menopause medications, and a NHANES study linking social disadvantage to earlier reproductive aging. Key Takeaways: • Melinda French Gates, with full access to elite medical care, still required three separate doctors before receiving a perimenopause diagnosis — illustrating how common diagnostic failure is in menopause care. • Medicaid patients are approximately half as likely to receive menopause medications compared to privately insured patients, according to new Medscape reporting. • A NHANES analysis spanning 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — is associated with a shorter reproductive lifespan. • Food security, housing status, education level, and income were all identified as significant individual contributors to earlier reproductive aging, suggesting menopause timing is partly shaped by social conditions, not just biology. • These three data points together describe a system where the women most likely to need support accessing menopause care are also the women most likely to enter menopause earlier and least likely to receive treatment for it. Sources & References: • Melinda French Gates on perimenopause: "It took me 3 doctors to really diagnose what I was going through" (https://news.google.com/rss/articles/CBMiigFBVV95cUxNU1pycko4bS14emR3dG9NekRMMnpsblJCdnlUOTM4YlVNdWR0OHRRRzNaZVpzbEQ2TkRaemthTW8xMlBlaXJnd2RlM09Hd3Z2d2RndVI1YkNRMTd0bUZrdHk4LW5zd2lnUFNnOWFOOHA5QUloaFNYRWExZWpnaDBGc21kS1VpNjlfT0E) - CBS News • Medicaid Patients Half as Likely to Get Menopause Meds (https://news.google.com/rss/articles/CBMipgFBVV95cUxPckRCRGI5ZmM0VUtIeU9uRzhyc2VQOTBtcF9wUGtyZGJWSE40X096c1o2d3pod2Q3ZHVic1JzVDI0aVZYWXNYZWd6bXpHaklEYTNUaWUtLWF5V3pDdFo1dTM0MU1lb1NUYjBDS1l4dHFLdWl5OFBFdG5CZDFaQlJJRzNabHdmWXhqaUw3R09hcmRiUkZBWGJienhEYWRtUWFrQnJWMHZR) - Medscape • Cumulative social determinants of health and reproductive lifespan among US women: NHANES 1999–2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-07-23-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  3. 3 gg fa

    Bones, Bladders, and the Smoking Study Nobody Asked For

    This episode covers three new studies published July 21, 2026: one on how women with limited incomes in China understand and practice bone health, one on the under-researched link between sleep apnea and overactive bladder in women, and one on smoking's relationship to breast density and cancer risk in Asian women. Nykki looks at what each one tells us — and what the research is still missing. Key Takeaways: • Many women aged 40–65 with limited income in China scored low on bone health *practices* even when awareness was moderate, pointing to a knowledge-to-action gap that isn't unique to any one country. • Obstructive sleep apnea is significantly underdiagnosed in women, and a 2026 narrative review found a meaningful association between OSA and overactive bladder symptoms — a connection that has been studied almost exclusively in male populations until recently. • Women with sleep apnea who are waking at night to urinate may be experiencing a physiological chain reaction tied to disrupted breathing, not just an isolated bladder issue. • The smoking and breast density study found that current smokers showed different breast density patterns compared to non-smokers, with implications for mammography sensitivity and cancer risk interpretation in Asian women. • All three studies share a design limitation worth noting: none of them establish causation, and two are population-specific in ways that limit how far you can generalize the findings. Sources & References: • Bone health attitudes and practices in women aged 40–65 with limited income in China (https://pubmed.ncbi.nlm.nih.gov/42480103/) - PubMed • Obstructive sleep apnea and overactive bladder: expanding the perspective to women (https://pubmed.ncbi.nlm.nih.gov/42479276/) - PubMed • Smoking habits, breast density changes, and breast cancer risk in Asian women (https://pubmed.ncbi.nlm.nih.gov/42479205/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-22-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  4. 4 gg fa

    Pain, Pee, and Peace of Mind: Three Symptoms Nobody Talks About Enough

    This episode goes deep on three underrecognized menopause symptoms: a decade-long review of pain across the transition, new diagnostic criteria for nighttime frequent urination, and a feasibility trial testing compassionate mind training for mood and anxiety. All three studies come from the NAMS journal and were published in July 2026. Key Takeaways: • Menopause-associated pain is not one thing — it spans joint pain, headaches, genitourinary pain, and more, each with different hormonal and psychosocial drivers, and a decade of research still hasn't produced a unified clinical framework for managing it. • Nighttime frequent urination (nocturnal polyuria) is a legitimate menopause symptom, but current diagnostic thresholds were built without adequately accounting for aging female physiology — a new framework proposes anchoring diagnosis to a nocturnal polyuria index of 28% plus symptom bother, which better reflects menopausal women's actual experience. • A small randomized feasibility trial found compassionate mind training — a structured group program rooted in self-compassion — was acceptable and feasible for women with menopause-related low mood and anxiety, with promising signals on mental health outcomes, though a fully powered trial is still needed. • The pain review specifically flags that psychosocial context — stress, sleep disruption, history of depression — amplifies menopause pain, which means treating it as purely hormonal will miss a significant part of what's driving it. • All three studies are in the same NAMS journal issue, and the collective gap they point to is the same: symptoms that real women are living with don't yet have the clinical infrastructure to be properly diagnosed and treated. Sources & References: • Menopause-associated pain: a decade review of patterns, determinants, and research priorities (https://pubmed.ncbi.nlm.nih.gov/42412599/) - Menopause (NAMS Journal) • Derivation and validation of a symptom-anchored diagnostic criterion for nocturnal polyuria in women (https://pubmed.ncbi.nlm.nih.gov/42413021/) - Menopause (NAMS Journal) • Group-based compassionate mind training for low mood and anxiety in the menopause transition: a feasibility RCT (https://pubmed.ncbi.nlm.nih.gov/42412587/) - Menopause (NAMS Journal) Listen with full show notes: https://hotflasher.com/episodes/2026-07-21-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  5. 5 gg fa

    Your Teeth, Your ZIP Code, and Your Heart: Menopause's Overlooked Trio

    This episode covers three research stories from July 2026: a new meta-analysis confirming resistance training's cardiovascular benefits for postmenopausal women, a large NHANES study linking social disadvantage to earlier menopause onset, and a Nature piece calling out England's Women's Health Strategy for ignoring dental health in 13 million menopausal women. Nykki takes positions on what the evidence actually supports, what the systemic failures look like, and why menopause timing isn't just biology. Key Takeaways: • A 2026 systematic review and meta-analysis found resistance training improves cardiovascular health markers in postmenopausal women — adding to a growing body of evidence that lifting is genuinely protective, not just aesthetic. • A NHANES analysis of US women from 1999–2018 found that cumulative social disadvantage — including food insecurity, housing instability, lower education, and lower income — was associated with a shorter reproductive lifespan, meaning earlier menopause. • Food security, housing status, education level, and income-to-poverty ratio were the strongest individual contributors within that social determinants mix. • A Nature-published commentary found that England's Women's Health Strategy makes no provision for the dental health of menopausal women, despite estrogen loss having well-documented effects on gum tissue, bone density in the jaw, and saliva production. • Menopause timing is not a purely biological event — where and how you live appears to shape when it happens, which has downstream implications for cardiovascular risk, bone density, and cognitive health. Sources & References: • Resistance Training Improves Cardiovascular Health in Postmenopausal Women: Systematic Review and Meta-Analysis (https://pubmed.ncbi.nlm.nih.gov/42470140/) - PubMed • Cumulative social determinants of health and reproductive lifespan among US women: a NHANES 1999-2018 analysis (https://pubmed.ncbi.nlm.nih.gov/42445967/) - Menopause (NAMS Journal) • Women's Health Strategy overlooks 13 million menopausal women's dental health (https://news.google.com/rss/articles/CBMiXkFVX3lxTE00UWsyTnQyV04xbVgycjB5XzFrOHBRMHpfb2MzWHhGSVQ3RlhrZEpWZE1IbzZFMDU2WHFfR2R1ZFlOeFJ4bWlqcUQ0b0h1N0V5aFlmczNiLWo5SEZzZFE?oc=5) - Nature / Google News Listen with full show notes: https://hotflasher.com/episodes/2026-07-20-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  6. 17 lug

    Your Zip Code, Your Bones, and the Calcium Question

    This episode covers three new studies published this week touching on women's health at midlife and beyond. Nykki looks at how neighborhood-level factors shape cardiovascular risk in midlife women, a major international consensus statement on pregnancy- and lactation-associated osteoporosis, and new longitudinal data on whether calcium supplements actually move the needle when you're already on bone-building medication. Key Takeaways: • A new study links neighborhood vulnerability — factors like poverty, lack of green space, and pollution exposure — to worse cardiovascular health in midlife women, independent of individual health behaviors. • Six international bone health organizations released a joint position statement on pregnancy- and lactation-associated osteoporosis (PLO), a rare but serious condition that is frequently missed or misdiagnosed because clinicians aren't trained to look for it. • A longitudinal observational study found that among older women already on antiresorptive osteoporosis treatment, additional calcium supplementation did not consistently produce better bone outcomes — dietary calcium intake may matter more than supplements. • The cardiovascular findings suggest that individual lifestyle advice is not sufficient when the environment itself is working against you — a public health problem that individual behavior change cannot solve. • For women with a history of pregnancy- or breastfeeding-related bone loss, the new PLO consensus statement is worth bringing to a clinician, as standardized guidance has previously been lacking. Sources & References: • Sociodemographic and neighborhood vulnerability linked to cardiovascular health in midlife women (https://pubmed.ncbi.nlm.nih.gov/42464805/) - PubMed • Pregnancy- and lactation-associated osteoporosis: joint position statement from IAPM, IOF, ECTS, ESCEO, IMS, and EMAS (https://pubmed.ncbi.nlm.nih.gov/42464584/) - PubMed • Dietary vs. supplemental calcium during antiresorptive osteoporosis treatment in older women (https://pubmed.ncbi.nlm.nih.gov/42463975/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-17-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  7. 16 lug

    Kidney Stones, Scotland's New Drug, and Menopause Goes to Work

    A new study published in the NAMS journal Menopause links premature menopause to significantly higher risk of kidney stone disease across two large datasets, including the UK Biobank. Scotland has approved the first non-hormonal menopause drug, expanding options for women who can't or won't use hormone therapy. And Washington State's governor has signed an executive order requiring workplace support for employees experiencing perimenopause and menopause. Key Takeaways: • Women who experienced premature menopause (before age 40) showed a consistently higher risk of kidney stone disease across both UK Biobank and NHANES cohorts, with the association holding up across multiple analytical methods. • Hormone therapy did not meaningfully modify the kidney stone risk, suggesting the connection may be driven by genetic or metabolic factors rather than estrogen loss alone. • Scotland has approved a non-hormonal drug for menopause symptoms — significant news for the substantial number of women who cannot use or choose not to use HRT. • Washington Governor Bob Ferguson signed an executive order directing state agencies to support employees experiencing perimenopause and menopause in the workplace, making Washington one of the more concrete US policy actors on this issue. • The kidney stone–premature menopause link is a reminder that early menopause has downstream health consequences beyond the cardiovascular and bone density risks that get most of the attention. Sources & References: • Premature menopause and risk of kidney stone disease: UK Biobank and NHANES evidence (https://pubmed.ncbi.nlm.nih.gov/42445973/) - Menopause (NAMS Journal) • First non-hormonal menopause drug approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxOSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c5b09sTmJ3?oc=5) - Medscape via Google News • Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace (https://news.google.com/rss/articles/CBMixwFBVV95cUxNdkFQMEtfUUp1QVpITmdaR0ljbVFnUWg3MFlYclprbTdfa2RMWjNIOU5aTWRSOFhJYU1TMXFfNnhkNUFjWWhOeHZSM19ER3JKYlEtN1pYbjF2YVdXeXJuR3dLR0dvN1QxVjVzTGFlSXdrMTQyelRXV1ppZUFFSzJybXJfVm82OUZUdWw1cjBIMHY1cEtvOWxHMEIxZmlDT1V0TUVVV1JZM1h5S216amZSQ2djSnlhcGloTHotcHJicDhORkQwSzNJ?oc=5) - Governor Bob Ferguson (.gov) via Google News Listen with full show notes: https://hotflasher.com/episodes/2026-07-16-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  8. 15 lug

    Your Medical Record Is Missing Half the Story

    A new study used Reddit posts to map menopause symptoms that consistently go undocumented in clinical records — and the gap is significant. Scotland has approved fezolinetant (Veoza), the first non-hormonal drug specifically licensed for menopause symptoms. And a 2026 PubMed study found that air pollution — specifically nitrogen oxide and sulfur dioxide — accelerates bone loss in postmenopausal women, with social determinants shaping who bears the most risk. Key Takeaways: • Reddit data revealed a wider range of menopause symptoms than what appears in clinical medical records, suggesting clinical documentation consistently undercaptures what women actually experience. • Scotland has approved fezolinetant (brand name Veoza), a neurokinin 3 receptor antagonist, as the first non-hormonal prescription option specifically licensed for menopause vasomotor symptoms. • A 2026 study published in PubMed found that nitrogen oxide and sulfur dioxide exposure is associated with measurable bone damage in postmenopausal women in the United States. • The air pollution–bone loss connection is shaped by social determinants — women with lower income and less access to resources face disproportionately higher risk from the same pollution levels. • Bone loss after menopause is not purely hormonal; environmental exposures and social circumstances are factors the standard clinical conversation almost never includes. Sources & References: • Reddit exposes menopause symptoms often missing from medical records (https://news.google.com/rss/articles/CBMitwFBVV95cUxOYjV6QmVBTjkzRl95S1NsbTJ5ajlseWltYlExZWlvSDhHTG1iT3dpSmZoWFEtWDJ0N1hGS0d5ODBkTURSOTN0d2JfcmdyMVB3NVBPUmhsX242R3VRZzRrRjBzbDlrZkk2ZjdSaE1JUjdYMGF0LV9FQmdRaFlUY1habHZEZUtnMGtWYTEwUlo1NUtTQm9zLVRkX0lWQzQyWm1kOWIxQ21rb1gxdzhlU21sT2JfQzNwWm8?oc=5) - News-Medical • First Non-Hormonal Menopause Drug Approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxPSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c1b09sTmJ3?oc=5) - Medscape • Social determinants of vulnerability to nitrogen oxide- and sulfur dioxide-related bone damage among postmenopausal women in the United States (https://pubmed.ncbi.nlm.nih.gov/42454308/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-15-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

Elenco completo (87)

Descrizione

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Informazioni

  • Creatore
    Hot Flasher
  • Anni di attività
    2026
  • Puntate
    87
  • Classificazione
    Contenuti adatti a tutti
  • Sito web del podcast
    Hot Flasher